Biotech Values

[Biowatch]

ANCN Legal questions asked...

NEW ORLEANS, Feb. 9, 2021 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Anchiano Therapeutics Ltd. (NasdaqGS: ANCN) with Chemomab Ltd. pursuant to which Anchiano shareholders will end up owning only approximately 10% of the combined company, prior to additional PIPE financing. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

https://finance.yahoo.com/news/anchiano-investor-alert-former-attorney-204300512.html

Not news per se, but maybe another “flash mob”???

Perhaps people misunderstood what a hypothetical “merger approved” means in this case....